EEG changes in 27 young healthy male right-handed volunteers on intermittent photic stimulation (IPS) were estimated using global field power (GFP), EEG microstate modeling and analysis (EMMA), and low-resolution electromagnetic brain tomography (LORETA). The GFP significantly increased at flashing frequency and high harmonics. Three model maps were extracted with the EMMA procedure, from which high alternation rates of each microstate were observed. Moreover, two of the three model maps contributed very highly, occurring most frequently. LORETA imaging of the three model maps obtained from the EMMA procedure showed that both visual dominant cortical areas were activated, especially in the left hemisphere. These results suggest that IPS does not cause peculiar spatial configurations of the brain electric field, but does cause acceleration and deviation of the microstate alternation. Also, a functional laterality between hemispheres might be enhanced by symmetric IPS.

Keywords:
Intermittent photic stimulation, Spatial analysis, Micro-state, EEG microstate modeling and analysis, Contribution, Alternation, Low-resolution electromagnetic tomography
This content is only available via PDF.
© 2001 S. Karger AG, Basel
2001
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.